{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T02:21:08Z","timestamp":1772763668182,"version":"3.50.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005422","name":"Gastrointestinal & Liver Diseases Research Center","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005422","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.dsx.2019.03.009","type":"journal-article","created":{"date-parts":[[2019,3,8]],"date-time":"2019-03-08T11:54:21Z","timestamp":1552046061000},"page":"1591-1596","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Prevalence of non-alcoholic fatty liver disease in patients with diabetes mellitus, hyperlipidemia, obesity and polycystic ovary syndrome: A cross-sectional study in north of Iran"],"prefix":"10.1016","volume":"13","author":[{"given":"Fariborz","family":"Mansour-Ghanaei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farahnaz","family":"Joukar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sahar Najafi","family":"Mobaraki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Mavaddati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soheil","family":"Hassanipour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masood","family":"Sepehrimanesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.dsx.2019.03.009_bib1","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.nutres.2013.11.005","article-title":"Cinnamon may have therapeutic benefits on lipid profile, liver enzymes, insulin resistance, and high-sensitivity C-reactive protein in nonalcoholic fatty liver disease patients","volume":"34","author":"Askari","year":"2014","journal-title":"Nutr Res"},{"issue":"3","key":"10.1016\/j.dsx.2019.03.009_bib2","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3945\/ajcn.113.068890","article-title":"Synbiotic supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study","volume":"99","author":"Eslamparast","year":"2014","journal-title":"Am J Clin Nutr"},{"issue":"16","key":"10.1016\/j.dsx.2019.03.009_bib3","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMra011775","article-title":"Nonalcoholic fatty liver disease","volume":"346","author":"Angulo","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.dsx.2019.03.009_bib4","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3748\/wjg.v18.i3.237","article-title":"Aging is a risk factor of nonalcoholic fatty liver disease in premenopausal women","volume":"18","author":"Hamaguchi","year":"2012","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.dsx.2019.03.009_bib5","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2036.2011.04724.x","article-title":"Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults","volume":"34","author":"Vernon","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.dsx.2019.03.009_bib6","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1042\/CS20070402","article-title":"Non-alcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenesis and treatment considerations","volume":"115","author":"Preiss","year":"2008","journal-title":"Clin Sci"},{"issue":"5","key":"10.1016\/j.dsx.2019.03.009_bib7","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.3390\/nu5051544","article-title":"Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease","volume":"5","author":"Gaggini","year":"2013","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.dsx.2019.03.009_bib8","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S1665-2681(19)30879-8","article-title":"The prevalence of nonalcoholic fatty liver disease in the Americas","volume":"13","author":"L\u00f3pez-Vel\u00e1zquez","year":"2014","journal-title":"Ann Hepatol"},{"issue":"2","key":"10.1016\/j.dsx.2019.03.009_bib9","doi-asserted-by":"crossref","first-page":"131","DOI":"10.15171\/mejdd.2016.18","article-title":"The prevalence of metabolic syndrome in non-alcoholic fatty liver disease; a population-based study","volume":"8","author":"Fattahi","year":"2016","journal-title":"Middle East J Dig Dis"},{"issue":"23","key":"10.1016\/j.dsx.2019.03.009_bib10","doi-asserted-by":"crossref","first-page":"23546","DOI":"10.1007\/s11356-016-7573-5","article-title":"Metabolic and endocrine effects of bisphenol A exposure in market seller women with polycystic ovary syndrome","volume":"23","author":"Vahedi","year":"2016","journal-title":"Environ Sci Pollut Control Ser"},{"issue":"1","key":"10.1016\/j.dsx.2019.03.009_bib11","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.dsx.2018.09.002","article-title":"Prevalence and associations of non-alcoholic fatty liver disease (NAFLD) in Sri Lankan patients with type 2 diabetes: a single center study","volume":"13","author":"Herath","year":"2019","journal-title":"Diabetes Metab Syndr"},{"issue":"6","key":"10.1016\/j.dsx.2019.03.009_bib12","doi-asserted-by":"crossref","first-page":"344","DOI":"10.4166\/kjg.2013.62.6.344","article-title":"Common carotid intima-media thickness in patients with non-alcoholic fatty liver disease: a population-based case-control study","volume":"62","author":"Lankarani","year":"2013","journal-title":"Korean J Gastroenterol"},{"issue":"1","key":"10.1016\/j.dsx.2019.03.009_bib13","first-page":"14","article-title":"Prevalence of nonalcoholic steatohepatitis in Iran: a population based study","volume":"2","author":"Sohrabpour","year":"2010","journal-title":"Middle East J Dig Dis"},{"issue":"1","key":"10.1016\/j.dsx.2019.03.009_bib14","first-page":"24","article-title":"Non-alcoholic steatohepatitis in a sample of iranian adult population: age is a risk factor","volume":"2","author":"Rogha","year":"2011","journal-title":"Int J Prev Med"},{"issue":"9","key":"10.1016\/j.dsx.2019.03.009_bib15","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.15419\/bmrat.v4i9.368","article-title":"The incidence and mortality of esophageal cancer and its relationship with development in the world","volume":"4","author":"Hassanipour","year":"2017","journal-title":"Biomed Res Therapy"},{"issue":"1","key":"10.1016\/j.dsx.2019.03.009_bib16","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.0197-3118.2006.05523.x","article-title":"Nonalcoholic steatohepatitis and the cardiometabolic syndrome","volume":"1","author":"Abdeen","year":"2006","journal-title":"J\u00a0Cardiometabolic Syndrome"},{"issue":"5","key":"10.1016\/j.dsx.2019.03.009_bib17","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)","volume":"311","author":"James","year":"2014","journal-title":"J\u00a0Am Med Assoc"},{"issue":"3","key":"10.1016\/j.dsx.2019.03.009_bib18","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S1665-2681(19)31922-2","article-title":"Prevalence of non-alcoholic fatty liver disease: population based study","volume":"6","author":"Amarapurkar","year":"2007","journal-title":"Ann Hepatol"},{"issue":"2","key":"10.1016\/j.dsx.2019.03.009_bib19","first-page":"128","article-title":"Prevalence of nonalcoholic fatty liver disease in subjects with metabolic syndrome","volume":"80","author":"Castro-Mart\u00ednez","year":"2011","journal-title":"Cir Cir"},{"issue":"5","key":"10.1016\/j.dsx.2019.03.009_bib20","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s00535-012-0533-z","article-title":"Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study","volume":"47","author":"Eguchi","year":"2012","journal-title":"J\u00a0Gastroenterol"},{"issue":"10","key":"10.1016\/j.dsx.2019.03.009_bib21","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1007\/s00535-003-1178-8","article-title":"Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background","volume":"38","author":"Kojima","year":"2003","journal-title":"J\u00a0Gastroenterol"},{"issue":"5","key":"10.1016\/j.dsx.2019.03.009_bib22","first-page":"e9248","article-title":"Non alcoholic fatty liver disease in southern Iran: a population based study","volume":"13","author":"Lankarani","year":"2013","journal-title":"Hepat Mon"},{"issue":"4","key":"10.1016\/j.dsx.2019.03.009_bib23","first-page":"503","article-title":"Risk factors for non-alcoholic fatty liver disease in a Chinese population","volume":"74","author":"He","year":"2011","journal-title":"Acta Gastro-Enterol Belg"},{"issue":"10","key":"10.1016\/j.dsx.2019.03.009_bib24","first-page":"584","article-title":"Nonalcoholic fatty liver disease in a cluster of Iranian population: thyroid status and metabolic risk factors","volume":"16","author":"Eshraghian","year":"2013","journal-title":"Arch Iran Med"},{"issue":"1","key":"10.1016\/j.dsx.2019.03.009_bib25","first-page":"9","article-title":"Non alcoholic fatty liver disease and metabolic syndrome","volume":"13","author":"Paschos","year":"2009","journal-title":"Hippokratia"},{"issue":"3","key":"10.1016\/j.dsx.2019.03.009_bib26","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1210\/jc.2015-3444","article-title":"Body mass index and risk of nonalcoholic fatty liver disease: two electronic health record prospective studies","volume":"101","author":"Loomis","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.dsx.2019.03.009_bib27","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ajg.2014.01.008","article-title":"Non alcoholic fatty liver disease (NAFLD) in a Sudanese population: what is the prevalence and risk factors?","volume":"15","author":"Almobarak","year":"2014","journal-title":"Arab J Gastroenterol"},{"issue":"1","key":"10.1016\/j.dsx.2019.03.009_bib28","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.dsx.2018.10.001","article-title":"Hyperuricemia as an independent risk factor for non-alcoholic fatty liver disease (NAFLD) progression evaluated using controlled attenuation parameter-transient elastography: lesson learnt from tertiary referral center","volume":"13","author":"Sandra","year":"2019","journal-title":"Diabetes Metab Syndr"},{"issue":"2","key":"10.1016\/j.dsx.2019.03.009_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0171502","article-title":"Prevalence and determinants of non-alcoholic fatty liver disease in lifelines: a large Dutch population cohort","volume":"12","author":"van den Berg","year":"2017","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.dsx.2019.03.009_bib30","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jceh.2015.09.001","article-title":"Risk factors associated with non-alcoholic fatty liver disease in indians: a case\u2013control study","volume":"5","author":"Singh","year":"2015","journal-title":"J\u00a0Clin Exp Hepatol"},{"issue":"3","key":"10.1016\/j.dsx.2019.03.009_bib31","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11894-016-0485-1","article-title":"Targeting lifestyle behavior change in adults with NAFLD during a 20-min consultation: summary of the dietary and exercise literature","volume":"18","author":"Hallsworth","year":"2016","journal-title":"Curr Gastroenterol Rep"},{"issue":"11","key":"10.1016\/j.dsx.2019.03.009_bib32","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1007\/s10620-015-3728-3","article-title":"Prevalence of nonalcoholic fatty liver disease and economy","volume":"60","author":"Zhu","year":"2015","journal-title":"Dig Dis Sci"},{"issue":"47","key":"10.1016\/j.dsx.2019.03.009_bib33","doi-asserted-by":"crossref","first-page":"6419","DOI":"10.3748\/wjg.v13.i47.6419","article-title":"Prevalence of fatty liver disease and its risk factors in the population of South China","volume":"13","author":"Zhou","year":"2007","journal-title":"World J Gastroenterol"},{"issue":"7","key":"10.1016\/j.dsx.2019.03.009_bib34","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/j.1478-3231.2006.01311.x","article-title":"Prevalence of primary non-alcoholic fatty liver disease in a population-based study and its association with biochemical and anthropometric measures","volume":"26","author":"Zelber-Sagi","year":"2006","journal-title":"Liver Int"},{"issue":"7","key":"10.1016\/j.dsx.2019.03.009_bib35","article-title":"Dietary quality indices and biochemical parameters among patients with non alcoholic fatty liver disease (NAFLD)","volume":"13","author":"Alavian","year":"2013","journal-title":"Hepat Mon"},{"issue":"3","key":"10.1016\/j.dsx.2019.03.009_bib36","first-page":"285","article-title":"A\u00a0case-control study on insulin resistance, metabolic co-variates & prediction score in non-alcoholic fatty liver disease","volume":"129","author":"Bajaj","year":"2009","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.dsx.2019.03.009_bib37","doi-asserted-by":"crossref","first-page":"5120760","DOI":"10.1155\/2016\/5120760","article-title":"Albumin binding function: the potential earliest indicator for liver function damage","volume":"2016","author":"Ge","year":"2016","journal-title":"Gastroenterol Res Pract"},{"issue":"6","key":"10.1016\/j.dsx.2019.03.009_bib38","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/j.1440-1746.2007.04952.x","article-title":"What are the risk factors and settings for non-alcoholic fatty liver disease in Asia\u2013Pacific?","volume":"22","author":"Fan","year":"2007","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"25","key":"10.1016\/j.dsx.2019.03.009_bib39","doi-asserted-by":"crossref","first-page":"8102","DOI":"10.3748\/wjg.v20.i25.8102","article-title":"Non-alcoholic fatty liver disease and thyroid dysfunction: a systematic review","volume":"20","author":"Eshraghian","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.dsx.2019.03.009_bib40","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1007\/s10620-011-2006-2","article-title":"Prevalence of hypothyroidism in nonalcoholic fatty liver disease","volume":"57","author":"Pagadala","year":"2012","journal-title":"Dig Dis Sci"},{"issue":"6","key":"10.1016\/j.dsx.2019.03.009_bib41","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1089\/thy.2011.0279","article-title":"Inverse association between serum free thyroxine levels and hepatic steatosis: results from the Study of Health in Pomerania","volume":"22","author":"Ittermann","year":"2012","journal-title":"Thyroid"},{"issue":"3","key":"10.1016\/j.dsx.2019.03.009_bib42","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1590\/S0004-28032011000300006","article-title":"Gluco-lipidic indices in treated hypothyroidism associated with nonalcoholic fatty liver disease","volume":"48","author":"Mazo","year":"2011","journal-title":"Arq Gastroenterol"},{"key":"10.1016\/j.dsx.2019.03.009_bib43","first-page":"461","article-title":"Nonalcoholic fatty liver disease, diet and gut microbiota","volume":"13","author":"Finelli","year":"2014","journal-title":"EXCLI J"},{"issue":"24","key":"10.1016\/j.dsx.2019.03.009_bib44","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.4254\/wjh.v7.i24.2522","article-title":"Dietary approach in the treatment of nonalcoholic fatty liver disease","volume":"7","author":"Ferolla","year":"2015","journal-title":"World J Hepatol"},{"issue":"4","key":"10.1016\/j.dsx.2019.03.009_bib45","first-page":"383","article-title":"The prevalence of nonalcoholic fatty liver disease and its association with lifestyle\/dietary habits among university faculty and staff in Chengdu","volume":"25","author":"Lei","year":"2012","journal-title":"Biomed Environ Sci"},{"issue":"2","key":"10.1016\/j.dsx.2019.03.009_bib46","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s12263-013-0383-1","article-title":"A\u00a0case\u2013control study on the effect of metabolic gene polymorphisms, nutrition, and their interaction on the risk of non-alcoholic fatty liver disease","volume":"9","author":"Miele","year":"2014","journal-title":"Genes Nutr"},{"issue":"5","key":"10.1016\/j.dsx.2019.03.009_bib47","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1002\/hep.23516","article-title":"Cigarette smoking exacerbates nonalcoholic fatty liver disease in obese rats","volume":"51","author":"Azzalini","year":"2010","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.dsx.2019.03.009_bib48","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3934\/molsci.2015.4.427","article-title":"Cigarette smoke may be an exacerbation factor in nonalcoholic fatty liver disease via modulation of the PI3K\/AKT pathway","volume":"2","author":"Ichimura","year":"2015","journal-title":"AIMS Mol Sci"},{"issue":"2","key":"10.1016\/j.dsx.2019.03.009_bib49","first-page":"115","article-title":"Active smoking, passive smoking, and risk of nonalcoholic fatty liver disease (NAFLD): a population-based study in China","volume":"23","author":"Liu","year":"2013","journal-title":"J\u00a0Epidemiol"},{"issue":"4","key":"10.1016\/j.dsx.2019.03.009_bib50","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.jhep.2010.07.040","article-title":"Smoking and severity of hepatic fibrosis in nonalcoholic fatty liver disease","volume":"54","author":"Zein","year":"2011","journal-title":"J\u00a0Hepatol"}],"container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402119300931?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402119300931?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T09:06:04Z","timestamp":1761728764000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402119300931"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S1871402119300931"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2019.03.009","relation":{},"ISSN":["1871-4021"],"issn-type":[{"value":"1871-4021","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence of non-alcoholic fatty liver disease in patients with diabetes mellitus, hyperlipidemia, obesity and polycystic ovary syndrome: A cross-sectional study in north of Iran","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dsx.2019.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Diabetes India. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}